![Jonathan Zung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Zung
Corporate Officer/Principal bei
CURIS, INC.
Vermögen: 4 966 $ am 31.08.2026
Profil
Jonathan B. Zung is Chief Development Officer at Curis, Inc. since 2023.
Formerly, Dr. Zung was Chief Development Officer at Evelo Biosciences, Inc. from 2021 to 2023, Chairman at Clinical Data Interchange Standards Consortium, Inc. from 2015 to 2021, President-Sponsor & CRO Programs at WIRB-Copernicus Group, Inc. from 2018 to 2020, Group President-Clinical Development at Labcorp Drug Development, Inc. from 2016 to 2018, VP & Head-Global Clinical Sciences & Operations at UCB SA from 2014 to 2016, President at Clintrax Global, Inc. Education includes a doctorate from Emory University and an undergraduate degree from Florida Institute of Technology, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CURIS, INC. 0,16 % | 07.07.2026 | 3.333 ( 0,16 % ) | 4 966 $ | 31.08.2026 |
Aktive Positionen von Jonathan Zung
| Unternehmen | Position | Beginn |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 01.05.2023 |
Ehemalige bekannte Positionen von Jonathan Zung
| Unternehmen | Position | Ende |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 03.03.2023 |
Clinical Data Interchange Standards Consortium, Inc.
 Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Develops data standards to streamline clinical research and enable connections to healthcare | Vorsitzender | 01.01.2021 |
WIRB- Copernicus Group, Inc.
 WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and ethical review services for human research | Corporate Officer/Principal | 01.12.2020 |
| COVANCE INC. | Corporate Officer/Principal | 01.04.2018 |
| UCB | Corporate Officer/Principal | 01.04.2016 |
Ausbildung von Jonathan Zung
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Florida Institute of Technology, Inc.
 Florida Institute of Technology, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Develops data standards to streamline clinical research and enable connections to healthcare | Commercial Services |
WIRB- Copernicus Group, Inc.
WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and ethical review services for human research | Commercial Services |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Clintrax Global, Inc.
 Clintrax Global, Inc. Engineering & ConstructionIndustrial Services Offers clinical trial contract negotiation and investigator payments services for pharmaceutical and biotechnology companies | Industrial Services |
